Stocks Pfizer Inc

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks edged lower at the open Friday, with investors unimpressed over earnings beats from Intel and JPMorgan Chase as well as economic readings in line with expectations.

  • Were you so preoccupied with tech on Thursday that you missed the important action in Pharma. If so, Pete Najarian has got you covered!

  • Sure you like his show, but what about his book? Peak inside the playbook of celebrity talk show titan, Regis Philbin.

  • Vivus is getting the JPMorgan Healthcare Conference off to a sexy start. The company announced this morning that its late-stage experimental erectile dysfunction drug apparently gets the job done in 15 minutes.

  • The traders are closely watching potential hot stocks ahead of the JPMorgan Health Care conference next week.

  • Jeff Kindler, Pfizer Chairman and CEO

    No one in their right mind, especially in this economy, likes to see someone lose their job. (Well, unless you really can't stand the person.) But, on the other hand, when you hear the top exec of the world's biggest drug company talk candidly about how much fat there was (is?) at Pfizer, can you really blame him for swinging the ax?

  • Bonds and certificates of deposit have long been considered safer investments than stocks. But in an era of incredibly low interest rates, Cramer said, buying the former two could be a mistake. A CD right now might offer a 1.5% return, while 10-year Treasurys pay you 3.75%. A company with a high-yielding dividend, however, can generate more than 7% (see: Kinder Morgan Energy Partners, among others). But even stocks with sub-4% yields these days may net more than those 10-years because dividends

    Read on for Cramer’s nine newest dividend plays. Just remember: The numbers listed here were correct as of publish time, but they may have changed a bit since. So do your homework!

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks rallied on the first trading day of the new year, buoyed by a trifecta of news: A report that showed growth in the manufacturing sector, the dollar's pullback and an upgrade on Intel.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks looks set to start the last day of 2009 with a slight gain, although volume could be thin with many investors looking to pop the champagne corks early.

  • dogs_ofthe_dow.jpg

    A popular investment strategy suggests buying the ten Dow Jones Industrial Average components with the highest yielding dividends. Here is the list going into 2010.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks looks set to start the last day of 2009 with a slight gain, although volume could be thin with many investors looking to pop the champagne corks early.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks looks set to start the last day of 2009 with a slight gain, although volume could be thin with many investors looking to pop the champagne corks early.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks erased their losses Wednesday — and the Dow and Nasdaq pulled off a gain — after a better-than-expected report on Midwest manufacturing.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks pared their losses Wednesday after a better-than-expected report on Midwest manufacturing.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stock index futures pointed to a lower start Wednesday, following a day where the market snapped its winning streak, trading in a very small range.

  • Best & Worst of the Decade

    Following the sizzling 1990s (the markets’ best decade ever), stocks have had a disappointing decade overall, fizzling in the 2000s.  Here are the best and worst of the Dow.

  • dogs_ofthe_dow.jpg

    A popular investment strategy suggests buying the ten Dow Jones Industrial Average components with the highest yielding dividends. Here is the list going into 2010.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks closed higher as a holiday rally got a further push from big technology, banks and commodities, though most investors took Christmas Eve off.

  • Winterizing Your Portfolio - A CNBC Special Report

    Futures mostly shrugged off news that weekly unemployment claims hit their lowest level in 15 months, but stocks were still poised for a gain in a holiday-shortened session Thursday.

  • pills_prescription_200.jpg

    I can’t wait until this drug rises to the level where it gets on Joe Kernen’s radar screen because, boy, is he gonna have a good time (not just with the drug perhaps, but mostly with talking on TV about it.) A little TMI, I know, but that’s Joe.